13F filing recap · Q3 2024
What did Brave Warrior Advisors buy in Q3 2024?
Reported stock-position changes between this filing and the previous one.
Stock value
$4.82B
Positions
32
Estimated turnover
16.1%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Brave Warrior Advisors opened new positions in Dollar Tree, Ally Financial, Moody’s, Texas Instruments, Mastercard, and S&P Global, while exiting Applied Materials. The firm added to TD Synnex, Lennar, and Ryanair, with the Ryanair increase standing out as dramatic. It trimmed Apollo Global Management substantially, and reduced Primerica, Fidelity National Financial, HCA Healthcare, and UnitedHealth Group.